Is this your app? Claim this page to add your own description, links and contact info. It's free. →
Version
2.5
Size
104.76 Mb
Updated
5 years ago
Released
16 May 2017
Screenshots
Description
DoctorOral is the first mobile app for those working in the health sector, including medical/dental professionals and medical/dental students.
In the form of a guided pathway, it provides:
1. a clinical framework for lesions in the oral cavity; and
2. the dental management of patients at risk of drug-related osteonecrosis of the jaw (ONJ).
1. The principal function of the app is simple but powerful, and based on the recognition of initial lesions in the oral cavity, differentiating them by colour/morphology and aetiology. Each pathway is guided questions and multiple-choice answers, leading to one or more diagnostic hypotheses. Each diagnostic hypothesis contains a summary and various clinical images of the disease, which provide further information about the lesion. In addition, the user will be able to take clinical photos of their own cases throughout the entire pathway for comparison with the final hypothesis/es, as suggested by the app.
Another special tool in the DoctorOral mobile app is that of requesting and making use of (at the end of the pathway) a teleconsultation via e-mail ([email protected]). However, this opinion is NOT intended as medical consultancy and/or the creation or provision of guidelines or recommendations. The user knowingly accepts the obligation to refer to medical criteria for the ascertaining of causal links, the principles of rule-based ethics and possible standards of care in diagnosing and caring for individual patients. Of the many functions found in the DoctorOral app, the user will be able to refer to some of the main and common pathologies of the oral cavity (“Synopses of Diseases”), “Primary Lesions” and the “Symbols Caption”.
2. Accessing the “Osteonecrosis Risk” page will enable to user to consult guided pathways regarding the dental treatment of oncological and osteometabolic patients, at risk of drug-related osteonecrosis of the jaw, both in the pre- and in post-therapy phases.
Estimates
Availability
Devices
iPad2Wifi
iPad23G
iPhone4S
iPadThirdGen
iPadThirdGen4G
iPhone5
iPodTouchFifthGen
iPadFourthGen
iPadFourthGen4G
iPadMini
iPadMini4G
iPhone5c
iPhone5s
iPadAir
iPadAirCellular
iPadMiniRetina
iPadMiniRetinaCellular
iPhone6
iPhone6Plus
iPadAir2
iPadAir2Cellular
iPadMini3
iPadMini3Cellular
iPodTouchSixthGen
iPhone6s
iPhone6sPlus
iPadMini4
iPadMini4Cellular
iPadPro
iPadProCellular
iPadPro97
iPadPro97Cellular
iPhoneSE
iPhone7
iPhone7Plus
iPad611
iPad612
iPad71
iPad72
iPad73
iPad74
iPhone8
iPhone8Plus
iPhoneX
iPad75
iPad76
iPhoneXS
iPhoneXSMax
iPhoneXR
iPad812
iPad834
iPad856
iPad878
Watch4
iPadMini5
iPadMini5Cellular
iPadAir3
iPadAir3Cellular
iPodTouchSeventhGen
iPhone11
iPhone11Pro
Watch5
iPadSeventhGen
iPadSeventhGenCellular
iPhone11ProMax
iPhoneSESecondGen
iPadProSecondGen
iPadProSecondGenCellular
iPadProFourthGen
iPadProFourthGenCellular
Pricing by country
| Country | Price |
|---|---|
| Canada | free |
| China | free |
| France | free |
| Germany | free |
| Italy | free |
| Netherlands | free |
| Portugal | free |
| Spain | free |
| Poland | free |
| UK | free |
| India | free |
| Japan | free |
| Korea, Republic Of | free |
| Poland | free |
| Russia | free |
| Turkey | free |
| USA | free |
| Korea, Republic Of | free |
| Ukraine | free |
